SCHEMBL869646

SCHEMBL869646

C[n+]1ccn(CCCc2ccccc2)c1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ NPSR1 Q6W5P4 2/20 0.51
▸ MEN1 O00255 1/20 0.51
▸ APAF1 O14727 1/20 0.51
▸ NPC1 O15118 1/20 0.51
▸ PLA2G1B P04054 1/20 0.51
▸ HSP90AA1 P07900 1/20 0.51
▸ MAPT P10636 1/20 0.51
▸ MAPK1 P28482 1/20 0.51
▸ HTT P42858 1/20 0.51
▸ RAB9A P51151 1/20 0.51
▸ KMT2A Q03164 1/20 0.51
▸ SMN1; SMN2 Q16637 1/20 0.51
▸ ATG4B Q9Y4P1 1/20 0.51
▸ SIGMAR1 Q99720 4/20 0.44
▸ GSK3A P49840 1/20 0.41
▸ GSK3B P49841 1/20 0.41
▸ MAOA P21397 1/20 0.41
▸ BCHE P06276 1/20 0.40
▸ ACHE P22303 1/20 0.40
▸ PON1 P27169 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Bromide SCHEMBL2835015 0.98 NPSR1 (0.54) NPSR1MEN1APAF1NPC1PLA2G1B
Hydrochloric Acid SCHEMBL1880315 0.98 NPSR1 (0.50) NPSR1MEN1APAF1NPC1PLA2G1B
SCHEMBL12558221 0.95 NPSR1 (0.54) NPSR1MEN1APAF1NPC1PLA2G1B
SCHEMBL2832102 0.94 NPSR1 (0.46) NPSR1MEN1APAF1NPC1PLA2G1B
SCHEMBL21314161 0.94 NPSR1 (0.46) NPSR1MEN1APAF1NPC1PLA2G1B
SCHEMBL21314159 0.90 MAPT (0.43) NPSR1MEN1APAF1NPC1PLA2G1B
SCHEMBL925001 0.90 KMT2A (0.46) NPSR1MEN1APAF1NPC1PLA2G1B
Hydrochloric Acid SCHEMBL8137482 0.88 KMT2A (0.45) NPSR1MEN1APAF1NPC1PLA2G1B
Trifluoromethanesulfonic Acid SCHEMBL2830949 0.85 NPSR1 (0.40) NPSR1MEN1APAF1NPC1PLA2G1B
SCHEMBL17316661 0.82 MEN1 (0.51) NPSR1MEN1APAF1NPC1PLA2G1B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 143 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4650498-A1 FLUID CONTACTING DEVICE Aurotec GmbH (AT) 2025-11-19 — — EP claimed
EP-1984438-B2 ANTISTATIC POLYURETHANE BASF SE (DE) 2016-05-18 — — EP claimed
US-20150057388-A1 ANTISTATIC POLYURETHANE BASF SE (DE) 2015-02-26 — — US claimed
EP-1812382-B1 METHOD FOR PRODUCING POLYISOCYANATES BASF SE (DE) 2013-01-23 — — EP claimed
JP-4794561-B2 — — 2011-10-19 — — JP claimed
US-7858802-B2 Method of preparing ionic liquids BASF SE (DE) 2010-12-28 — — US claimed
EP-1984438-B1 ANTISTATIC POLYURETHANE BASF SE (DE) 2010-03-31 — — EP claimed
US-7659430-B2 Method for separating hydrogen chloride and phosgene BASF AKTIENGESELLSCHAFT (DE) 2010-02-09 — — US claimed
US-20090300946-A1 ANTISTATIC POLYURETHANE BASF SE (DE) 2009-12-10 — — US claimed
EP-1789160-B1 METHOD FOR SEPARATING HYDROGEN CHLORIDE AND PHOSGENE BASF SE (DE) 2009-11-18 — — EP claimed
US-20070293707-A1 Method for Separating Hydrogen Chloride and Phosgene BASF AKTIENGESELLSCHAFT (DE) 2007-12-20 — — US claimed
WO-2007090755-A1 ANTISTATIC POLYURETHANE BASF AKTIENGESELLSCHAFT (DE) 2007-08-16 — — WO claimed
EP-1812382-A1 METHOD FOR PRODUCING POLYISOCYANATES BASF AKTIENGESELLSCHAFT (DE) 2007-08-01 — — EP claimed
EP-1805206-A2 ELECTROCHEMICAL DEBLOCKING USING A HYDRAZINE DERIVATIVE Combimatrix Corporation (US) 2007-07-11 — — EP claimed
EP-1789160-A1 METHOD FOR SEPARATING HYDROGEN CHLORIDE AND PHOSGENE BASF AKTIENGESELLSCHAFT (DE) 2007-05-30 — — EP claimed
WO-2007006418-A1 IONIC-LIQUID-CONTAINING PRODUCTS FOR DYEING AND/OR BRIGHTENING KERATIN FIBRES HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (DE) 2007-01-18 — — WO claimed
WO-2006131234-A1 COSMETIC COMPOSITIONS COMPRISING IONIC LIQUIDS HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (DE) 2006-12-14 — — WO claimed
WO-2006048171-A1 METHOD FOR PRODUCING POLYISOCYANATES BASF AKTIENGESELLSCHAFT (DE) 2006-05-11 — — WO claimed
WO-2006029788-A1 METHOD FOR SEPARATING HYDROGEN CHLORIDE AND PHOSGENE BASF AKTIENGESELLSCHAFT (DE) 2006-03-23 — — WO claimed
WO-2006031814-A2 ELECTROCHEMICAL DEBLOCKING USING A HYDRAZINE DERIVATIVE COMBIMATRIX CORPORATION (US) 2006-03-23 — — WO claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070293707-A1 Method for Separating Hydrogen Chloride and Phosgene PSPH, SLC9B2, HVCN1 NPSR1 2750/4885MEN1 846/4885APAF1 4401/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback